salivaricin A

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Streptococcus agalactiae (group B streptococcus [GBS]) colonizes the rectovaginal tract in 20% to 30% of women and during… (More)
Is this relevant?
2015
2015
Microbial communities inhabiting the breast milk microenvironment are essential in supporting mammary gland health in lactating… (More)
Is this relevant?
2012
2012
Bacteriocins are antimicrobial peptides with potential applications as therapeutic agents for the treatment of microbial… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2009
2009
The background to the discovery and commercial development of the first Streptococcus salivarius probiotic is documented. A 40… (More)
Is this relevant?
2007
2007
The colonization efficacies of salivaricin A (SalA)-producing Streptococcus salivarius strains 20P3 and 5 were compared when… (More)
Is this relevant?
2006
2006
Salivaricin A (SalA), the first Streptococcus salivarius lantibiotic to be characterized, appears to be inhibitory to most… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2006
2006
Streptococcus salivarius strains commonly produce bacteriocins as putative anticompetitor or signalling molecules. Here we report… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Streptococcus salivarius 20P3 produces a 22-amino-acid residue lantibiotic, designated salivaricin A (SalA), that inhibits the… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
A bacteriocin-like inhibitory substance, salivaricin A, was purified from cultures of Streptococcus salivarius 20P3 and was shown… (More)
Is this relevant?